TWIST1, CSF1, and CD68 proteins expression levels were investigated in relation to the clinicopathological parameters using an independent cohort of tissue samples from 141 patients with oral cancer (Table S2) who had tumor relapse (n = 44; 31.2%) or distant metastasis and patients ith good outcomes (n = 97; 68.8%). This evidence concerns the gene TWIST1 and lip and oral cavity carcinoma.